Zevra Therapeutics (ZVRA) Restructuring Costs (2016 - 2020)

Zevra Therapeutics (ZVRA) has 3 years of Restructuring Costs data on file, last reported at -$2000.0 in Q4 2020.

• Quarterly Restructuring Costs changed N/A year-over-year to -$2000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2021 was -$2000.0 (down 100.24% YoY) and the FY2020 annual result came in at $828000.0, changed N/A from the prior year.
• Restructuring Costs eased to -$2000.0 in Q4 2020, from $830000.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $3.0 million in Q3 2016 to a low of -$2000.0 in Q4 2020.
• A 3-year average of $1.4 million and a median of $1.2 million in 2018 frame the typical range for Restructuring Costs.